Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial)

ClinicalTrials.gov ID: NCT04865770

Public ClinicalTrials.gov record NCT04865770. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 10:43 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Renal Mode of Action of Semaglutide in Patients With Type 2 Diabetes and Chronic Kidney Disease

Study identification

NCT ID
NCT04865770
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
106 participants

Conditions and interventions

Interventions

  • Semaglutide Drug
  • Placebo (Semaglutide) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 27, 2021
Primary completion
Nov 20, 2024
Completion
Nov 20, 2024
Last update posted
Feb 9, 2026

2021 – 2024

United States locations

U.S. sites
20
U.S. states
12
U.S. cities
17
Facility City State ZIP Site status
University of Arizona-CaTs Tucson Arizona 85724
Academic Medical Research Institute Los Angeles California 90022
Roderick A. Comunale II MD Inc. National City California 91950
N America Res Inst - San Dimas San Dimas California 91773
UC Anschutz Medical Campus Aurora Colorado 80045
Advent Health-Res Inst Orlando Florida 32804
Atlanta Diabetes Associates Atlanta Georgia 30318
Emory University Hsptl - Atlanta Atlanta Georgia 30322
Endeavor Health Glenbook Hosp Evanston Illinois 60201
North Suburban Nephrology LLC Gurnee Illinois 60031
University of Minnesota Health Clinical Minneapolis Minnesota 55455
Clinical Research Consultants, LLC Kansas City Missouri 64111
Cleveland Clinic_Cleveland Cleveland Ohio 44195
Prolato Clinical Research Cntr Houston Texas 77054
Sun Research Institute San Antonio Texas 78215
NE Clin Res of San Antonio San Antonio Texas 78233
University of Texas San Antonio San Antonio Texas 78284
Univ of Washington Med Ctr Seattle Washington 98195
Providence Medical Research Center Spokane Washington 99204
Medical College Of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 29 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04865770, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 9, 2026 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04865770 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →